Microbot Medical Inc Cash Flow Conversion Efficiency
Microbot Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Microbot Medical Inc (MBOT) has a cash flow conversion efficiency ratio of -0.068x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.05 Million) by net assets ($74.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Microbot Medical Inc (1991–2025)
Cash flow conversion efficiency of Microbot Medical Inc from 1991 to 2025. This chart illustrates how Microbot Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Microbot Medical Inc (MBOT) stock price for real-time trading data and today's change.
Microbot Medical Inc Cash Flow Conversion Ratio Explained
Microbot Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Microbot Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbot Medical Inc ranked by their cash flow conversion efficiency. Also see market cap of Microbot Medical Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Unitronics
TA:UNIT
|
0.153x |
|
Woorison F&G Co. Ltd
KQ:073560
|
0.033x |
|
Ko Ja Cayman Co Ltd
TW:5215
|
0.019x |
|
Speciality Restaurants Limited
NSE:SPECIALITY
|
0.091x |
|
EN Shoham Business Ltd
TA:SHOM
|
-0.068x |
|
Asian Insulators PCL
BK:AI
|
0.030x |
|
CKM Building Material
TWO:8930
|
0.018x |
|
Resource Mining Corporation Ltd
AU:RMI
|
-0.078x |
Annual Cash Flow Conversion Efficiency for Microbot Medical Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Microbot Medical Inc from 1991 to 2025. Review Microbot Medical Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $77.55 Million | $-13.05 Million | -0.168x | +93.27% |
| 2024-12-31 | $3.53 Million | $-8.83 Million | -2.501x | -31.90% |
| 2023-12-31 | $4.50 Million | $-8.53 Million | -1.896x | -19.65% |
| 2022-12-31 | $7.29 Million | $-11.55 Million | -1.584x | -143.59% |
| 2021-12-31 | $14.38 Million | $-9.35 Million | -0.650x | -118.02% |
| 2020-12-31 | $24.31 Million | $-7.25 Million | -0.298x | -45.86% |
| 2019-12-31 | $31.54 Million | $-6.45 Million | -0.205x | +94.88% |
| 2018-12-31 | $1.33 Million | $-5.31 Million | -3.992x | -719.22% |
| 2017-12-31 | $9.96 Million | $-4.86 Million | -0.487x | -5.16% |
| 2016-12-31 | $1.70 Million | $-786.00K | -0.463x | -120.23% |
| 2015-12-31 | $-334.00K | $-765.00K | 2.290x | +149.16% |
| 2014-12-31 | $5.87 Million | $-27.35 Million | -4.659x | -198.73% |
| 2013-12-31 | $14.95 Million | $-23.32 Million | -1.560x | -9.77% |
| 2012-12-31 | $13.98 Million | $-19.87 Million | -1.421x | +30.92% |
| 2011-12-31 | $10.73 Million | $-22.06 Million | -2.057x | -29.85% |
| 2010-12-31 | $15.48 Million | $-24.52 Million | -1.584x | -95.69% |
| 2009-12-31 | $30.50 Million | $-24.68 Million | -0.809x | +22.38% |
| 2008-12-31 | $21.81 Million | $-22.74 Million | -1.043x | -76.04% |
| 2007-12-31 | $35.21 Million | $-20.86 Million | -0.592x | -100.00% |
| 2006-12-31 | $54.38 Million | $-16.10 Million | -0.296x | +19.23% |
| 2005-12-31 | $32.38 Million | $-11.87 Million | -0.367x | -20.17% |
| 2004-12-31 | $36.95 Million | $-11.27 Million | -0.305x | +60.84% |
| 2003-12-31 | $10.96 Million | $-8.54 Million | -0.779x | +70.74% |
| 2002-12-31 | $3.79 Million | $-10.09 Million | -2.663x | -234.50% |
| 2001-12-31 | $13.21 Million | $-10.52 Million | -0.796x | -189.61% |
| 2000-12-31 | $22.98 Million | $-6.32 Million | -0.275x | +92.28% |
| 1999-12-31 | $3.51 Million | $-12.49 Million | -3.562x | -593.02% |
| 1998-12-31 | $17.90 Million | $-9.20 Million | -0.514x | -7.64% |
| 1997-12-31 | $28.90 Million | $-13.80 Million | -0.478x | -65.70% |
| 1996-12-31 | $34.70 Million | $-10.00 Million | -0.288x | -227.09% |
| 1995-12-31 | $45.40 Million | $-4.00 Million | -0.088x | +85.14% |
| 1994-12-31 | $22.60 Million | $-13.40 Million | -0.593x | -71.90% |
| 1993-12-31 | $34.50 Million | $-11.90 Million | -0.345x | -13.17% |
| 1992-12-31 | $29.20 Million | $-8.90 Million | -0.305x | +10.95% |
| 1991-12-31 | $14.90 Million | $-5.10 Million | -0.342x | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more